AQR Arbitrage’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-75,021
Closed -$5.63K 1039
2023
Q1
$5.63K Sell
75,021
-927
-1% -$51 ﹤0.01% 938
2022
Q4
$387 Hold
75,948
﹤0.01% 1203
2022
Q3
$6K Hold
75,948
﹤0.01% 1237
2022
Q2
$8K Hold
75,948
﹤0.01% 1272
2022
Q1
$27K Buy
+75,948
New +$30.8K ﹤0.01% 1058

AQR Arbitrage's LVACW Position: Q2 2023 in Review

AQR Arbitrage sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 75,021 shares — an estimated $5.63K sold.

AQR Arbitrage first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $27K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

  • AQR Arbitrage reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
  • AQR Arbitrage sold 75,021 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $5.63K.
  • AQR Arbitrage first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
  • AQR Arbitrage's LAVA Medtech Acquisition Corp. Warrants position peaked at $27K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on AQR Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.